Literature DB >> 6327316

Daytime acid secretion after a single dose of ranitidine and cimetidine--a double blind crossover study.

V F Eckardt, I Cordes, H D Janisch, H Wiemann.   

Abstract

The purpose of the study was to evaluate the duration of inhibition of acid secretion by single oral doses of cimetidine and ranitidine. Basal and postprandial acid secretion in 6 healthy volunteers were measured for 14h by intermittent aspiration and prolonged intragastric titration. 400 mg cimetidine reduced daytime acid secretion by 22% and 150 mg ranitidine produced 38% inhibition. Although the elimination half lives of the drugs were similar, ranitidine led to more pronounced inhibition of acid secretion during the later part of the day. The longer duration of pronounced acid inhibition by ranitidine appears to be due solely to its greater potency.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327316     DOI: 10.1007/bf00630283

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine.

Authors:  W C Randolph; V L Osborne; S S Walkenstein; A P Intoccia
Journal:  J Pharm Sci       Date:  1977-08       Impact factor: 3.534

2.  Ranitidine in the treatment of duodenal ulceration.

Authors:  N R Peden; E J Boyd; J H Saunders; K G Wormsley
Journal:  Scand J Gastroenterol       Date:  1981-04       Impact factor: 2.423

3.  Cimetidine suppression of nocturnal gastric secretion in active duodenal ulcer.

Authors:  G F Longstreth; V L Go; J R Malagelada
Journal:  N Engl J Med       Date:  1976-04-08       Impact factor: 91.245

Review 4.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

5.  Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.

Authors:  R P Walt; I F Trotman; R Frost; P L Golding; T H Shepherd; J Rawlings; R H Hunt; D Colin-Jones; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

6.  Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer.

Authors:  J S Fordtran; J H Walsh
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

7.  Clinical comparison of cimetidine and ranitidine.

Authors:  D C Brater; M N Peters; F N Eshelman; C T Richardson
Journal:  Clin Pharmacol Ther       Date:  1982-10       Impact factor: 6.875

8.  Impaired cimetidine absorption due to antacids and metoclopramide.

Authors:  R Gugler; M Brand; A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Determination of ranitidine and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatography.

Authors:  P F Carey; L E Martin; P E Owen
Journal:  J Chromatogr       Date:  1981-09-11

10.  Tiotidine and cimetidine--kinetics and dynamics.

Authors:  S Kaojarern; M Feldman; C T Richardson; D C Brater
Journal:  Clin Pharmacol Ther       Date:  1981-02       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.